
The BIOMEDICAN founder has spent two decades moving between genomes, models and microbes. His current wager is simple to describe and difficult to execute: make scarce compounds in fermentation tanks instead of fields.
The Fremont biotech says its engineered Yarrowia yeast can brew rare cannabinoids in days at 70-90% below conventional costs. The clever part is not cannabis at all - it is a reusable fermentation platform, and the hard part is proving that lab economics survive the factory floor.